stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).Ĭardinal Health Inc. The earnings rating for Cardinal Health Inc.
is Hold (2.55), with a target price of $60.25, which is -19.83% compared to the current price. The consensus rating of Wall Street analysts for Cardinal Health Inc.
Cardinal Health Inc.’s next earnings report date is 04th Nov 2022. The company has EPS estimate of $0.96 for the next earnings report. Of the last four earnings reports from Cardinal Health Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company’s profit margin is -0.83%, its EBITDA margin is 0.10%, and its revenue ttm is $137.40 Billion, which makes it $524.39 revenue per share. currently has a PE ratio of -22.20, a price-to-book (PB) ratio of 16.07, a price-to-sale (PS) ratio of 0.14, a price to cashflow ratio of 6.90, a PEG ratio of 2.32, a ROA of -2.24%, a ROC of -12.80% and a ROE of -213.58%. Its 52-week range is between 45.85 and 77.195, which gives CAH stock a 52-week price range ratio of 93.36%Ĭardinal Health Inc. CAH stock has a five-year performance of 23.45%. stock is 54.2%, while year-to-date (YTD) performance is 46.42%. The one-year performance of Cardinal Health Inc. The company belongs in the Medical Distribution industry, Healthcare sector and employs 47300 people. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. (NYSE: CAH) stock closed at 75.39 per share at the end of the most recent trading day (a -0.67% change compared to the prior day closing price) with a volume of 2.98M shares and market capitalization of 19.68B.
0 kommentar(er)
